about
Components of cultural competence in three mental health programs.Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization.The Nathan Kline Institute cultural competency assessment scale: psychometrics and implications for disparity reduction.Outcome in schizophrenia and related disorders compared between developing and developed countries. A recursive partitioning re-analysis of the WHO DOSMD data.Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.Declining use of electroconvulsive therapy in United States general hospitals.Making the cut: Depression screening in urban general hospital clinics for culturally diverse Latino populations.Analgesic efficacy of piroxicam in the treatment of postoperative pain.Cost-Shifting from Private to Public Payers: The Scene Before Parity Legislation.Automated review system for orders of psychotropic drugs.Prevalence and Diagnosis Rates of Childhood ADHD Among Racial-Ethnic Groups in a Public Mental Health System.Coping with disasters: estimation of additional capacity of the mental health sector to meet extended service demands.Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City.Estimating population size and duplication rates when records cannot be linked.Estimating treated prevalence and service utilization rates: assessing disparities in mental health.Mental illness among homeless individuals in a suburban county.The correlation between blood levels of ibuprofen and clinical analgesic response.Pharmacotherapy of the hospitalized young adult schizophrenic patient.The dynamics of hospitalization in a defined population during deinstitutionalization.Performance measures and their benchmarks for assessing organizational cultural competency in behavioral health care service delivery.Power and sample size in cost-effectiveness analysis.Cultural Activation of Consumers.Performance measures of cultural competency in mental health organizations.Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression.Access to and use of non-inpatient services in New York State among racial-ethnic groups.A risk-based prospective payment system that integrates patient, hospital and national costs.Outcomes of The BODY Project: A Program to Halt Obesity and Its Medical Consequences in High School Students.Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000.Estimating capacity requirements for mental health services after a disaster has occurred: a call for new data.Statistical determination of cost-effectiveness frontier based on net health benefits.A survey of hospitals in New York State treating psychiatric patients with chemical abuse disorders.Statistical cost-effectiveness analysis of two treatments based on net health benefits.An alternative to DRGs. A clinically meaningful and cost-reducing approach.Alternatives to DRGs: research issues.Severe alcoholism in the mental health sector: II. Effects of service utilization on readmission.Acceptance and impact of the computer in clinical decisions.Mortality in the era of deinstitutionalization.The relationship between socioeconomic class and prevalence of schizophrenia, alcoholism, and affective disorders treated by inpatient care in a suburban area.Quantitative care norms for a psychiatric ambulatory population in a county medical assistance program.Statistical inference for cost-effectiveness ratios.
P50
Q30403359-06D7E699-E2FB-48B3-B555-8E02FA224535Q34063631-1F2EDEBA-2031-4065-9898-139971F63A9CQ35040877-503335A7-E8D3-4384-ABEC-6A0F992D40FDQ36871860-72081194-654C-40E8-A078-9B53A2F22C01Q37281750-C46EF00A-86F9-43BF-AEAA-A8C2F3787443Q37732259-A00101CB-EC76-4A04-AB20-7027DF6DED76Q39168983-154249E4-FCCB-4294-A797-2641E02044B0Q39532000-0F769582-1946-4076-B002-A38A1CDAEC2EQ39600231-99F8BEE4-FEF9-4A66-A815-2F96C904D0D3Q40362573-7784AE97-BAC6-47B5-AAEB-9D3A4979120CQ40481940-D3386536-90B7-4ECF-9BC6-1AC4D1309FC7Q40496573-C2811F02-3313-4F6D-A484-F68533E6DECBQ41209394-811FB2E9-211A-4DDE-8584-6BCB484EA8F3Q42611277-8309CE2D-FC9B-4F0E-9E34-C9222A309327Q43451685-C6CDA03E-E199-42B5-AC70-F2FA0141E5E7Q43674660-2356A4C9-AD64-41D9-BA9E-CC19F8462954Q43780693-C3159380-BBA1-4B56-AA8F-F210AC7770BEQ44728763-930CB823-D7FC-48CD-8D28-2CAF6A58A771Q45155151-251E7022-C537-40C9-824A-E032996AC0ADQ47224958-20067F79-A5EF-433B-92C9-C59B9FE21B58Q47260518-5C80A797-9B4F-440B-AC0D-7A732BA4B3AFQ47371677-B0DBE094-B6C6-4F62-B1B3-F08364066F55Q47640035-20B052CF-91CD-4AE3-A1D1-486424E0D367Q48459590-DEE121B0-803C-49E8-9701-32DB491763FDQ48501439-3FEACE58-64A9-422A-B873-BFB5B2A4DF48Q50131429-7BA2C78E-FB07-4F9B-87C4-A12F9A88D7A2Q50551941-83A0C5C9-E68D-4101-A346-1AE80068F787Q51908371-CA530079-5230-4533-AFA3-983C12E37446Q51942065-86659A0F-E0B9-4CB1-AFFD-1DE5D7F3BEB0Q52043708-D0705536-8122-469E-999B-D8BD80599A8CQ52047480-FDC3E45D-56F2-4073-AC9A-9E3EA5D8D365Q52065721-806E736C-FE14-4C16-A51D-2C8889298FA4Q52079027-DD5474C1-B170-442A-AAEE-592AD2733810Q52090416-8E6CBBE5-BBB8-4455-A36B-2C9FA687FDD5Q52091151-042BC969-CD24-45E6-917D-C4D29C9C0662Q52091696-93495416-2205-41EF-9A8A-D3DFC8742F83Q52095115-6CF4B5FF-3CFE-4F9E-809E-2D1FFC2C6623Q52096221-BC5C695E-4A64-4020-AE0A-9A810E9E737CQ52109004-FB9FB7D0-2E70-401F-8D0C-2BC5318AD3D5Q52265200-973E18DF-61EC-49A3-9376-98D0BCB598B5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carole Siegel
@ast
Carole Siegel
@en
Carole Siegel
@es
Carole Siegel
@nl
Carole Siegel
@sl
type
label
Carole Siegel
@ast
Carole Siegel
@en
Carole Siegel
@es
Carole Siegel
@nl
Carole Siegel
@sl
prefLabel
Carole Siegel
@ast
Carole Siegel
@en
Carole Siegel
@es
Carole Siegel
@nl
Carole Siegel
@sl
P106
P21
P31
P496
0000-0002-7460-788X